Position
Squarepoint Ops LLC in Biocryst Pharmaceuticals Inc
Back to the book · All holders of BCRX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $68.4K$7.80 → $9.52
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.66M | $12.9M | — | — | — | 0.0% |
| Q1 2026 | 39.8K | $378.6K | $9.52 | $68.4K | −$12.6M | 0.0% |